Prevalence of complementary and alternative medicine use in cancer patients during treatment

Jennifer Yates1, Karen M. Mustian2, Gary R. Morrow2, Leslie Gillies2, Devi Padmanaban2, James N. Atkins3, Brian F. Issell4, Jeffrey J. Kirshner5, Lauren K. Colman6
1James P Wilmot Cancer Center, University of Rochester, Rochester, USA
2James P Wilmot Cancer Center, University of Rochester, Rochester, NY, USA
3Southeast Cancer Control Consortium, Winston-Salem, NC, USA
4Cancer Research Center of Hawaii, Honolulu, HI, USA
5Syracuse Hematology-Oncology CCOP, Syracuse, NY, USA
6Northwest CCOP, Tacoma, WA, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adler SR, Fosket JR (1999) Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract 48:453–458

American Cancer Society (2005) Statistics for 2004. http://www.cancer.org/docroot/STT/stt_0.asp

Balneaves LG, Kristjanson LJ, Tataryn D (1999) Beyond convention: describing complementary therapy use by women living with breast cancer. Patient Educ Couns 38:143–153

Begbie SD, Kerestes ZL, Bell DR (1996) Patterns of alternative medicine use by cancer patients. Med J Aust 165:545–548

Bernstein BJ, Grasso T (2001) Prevalence of complementary and alternative medicine use in cancer patients. Oncology 15:1267–1272

Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18:2515–2521

Canales MK, Geller BM (2003) Surviving breast cancer: the role of complementary therapies. Fam Commun Health 26:11–24

Dooley MJ, Lee DY, Marriott JL (2004) Practitioners’ sources of clinical information on complementary and alternative medicine in oncology. Support Care Cancer 12:114–119

Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, Slevin ML (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309:86–89

Ernst E (2000) The role of complementary and alternative medicine in cancer. Lancet Oncol 1:176–180

Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83:777–782

Feather BL, Wainstock JM, Remington A, Ringenberg QS (1988) Postmastectomy educational needs and social support. J Cancer Educ 3:135–144

Henderson JW, Donatelle RJ (2004) Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med 10:52–57

Jordan ML, Delunas LR (2001) Quality of life and patterns of nontraditional therapy use by patients with cancer. Oncol Nurs Forum 28:1107–1113

Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47

Lengacher CA, Bennett MP, Kip KE, Keller R, LaVance MS, Smith LS, Cox CE (2002) Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 29:1445–1452

Morris KT, Johnson N, Homer L, Walts D (2000) A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 179:407–411

Morrow GR, Hickok JT, Burish TG, Rosenthal SN (1996) Frequency and clinical implications of delayed nausea and delayed emesis. Am J Clin Oncol 19:199–203

Munstedt K, Kirsch K, Milch W, Sachsse S, Vahrson H (1996) Unconventional cancer therapy—survey of patients with gynecological malignancy. Arch Gynecol Obstet 258:81–88

Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, Jones KL, Bodurka DC, Basen-Engquist K, Hortobagyi GN, Kavanagh JJ, Smith JA (2004) An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 22:671–677

NCCAM (2002) What is complementary and alternative medicine (CAM)? (publication no. D156). NCCAM, National Institutes of Health, Bethesda, MD

Newell S, Sanson-Fisher RW (2000) Australian oncologists’ self-reported knowledge and attitudes about non-traditional therapies used by cancer patients. Med J Aust 172:110–113

Ott MJ, Lynch M (2002) Integrating complementary and conventional symptom management in a cancer center. Oncol Nurs Forum 29:25–27

Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, Marshall LM (2002) Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8:477–485

Ponholzer A, Struhal G, Madersbacher S (2003) Frequent use of complementary medicine by prostate cancer patients. Eur Urol 43:604–608

Redeker NS, Lev EL, Ruggiero J (2000) Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 14:275–290

Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514

Richardson MA, Straus SE (2002) Complementary and alternative medicine: opportunities and challenges for cancer management and research. Semin Oncol 29:531–545

Risberg T, Kaasa S, Wist E, Melsom H (1997) Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer 33:575–580

Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19:895–908

Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, Steinberg SM, Wootton J (2000) Use of complementary medicine by adult patients participating in cancer control trials. Oncol Nurs Forum 27:623–630

Verhoef MJ, Hilsden RJ, O’Beirne M (1999) Complementary therapies and cancer care: an overview. Patient Educ Couns 38:93–100

White JD (2002) Complementary and alternative medicine research: a National Cancer Institute perspective. Semin Oncol 29:546–551